Wellington Management Group

Wellington Management Group’s Protagonist Therapeutics PTGX Stock Holding History

Wellington Management Group’s Portfolio PTGX Stock Details PTGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$379M	Buy	3,599,644 +428,221	+14%	+$37.9M	0.07%	244
2025 Q4	$277M	Buy	3,171,423 +1,262,977	+66%	+$103M	0.05%	314
2025 Q3	$127M	Buy	1,908,446 +870,708	+84%	+$49.5M	0.02%	499
2025 Q2	$57.4M	Buy	1,037,738 +50,368	+5%	+$2.42M	0.01%	649
2025 Q1	$47.7M	Buy	987,370 +47,293	+5%	+$1.98M	0.01%	693
2024 Q4	$36.3M	Buy	940,077 +909,998	+3,025%	+$39.7M	0.01%	800
2024 Q3	$1.35M	Buy	+30,079	New	+$1.22M	﹤0.01%	1658

Other funds holding PTGX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return